Share

Shock to the System: Pediatric Type 1 Diabetes Patients and Trauma

A new study seems to suggest that while trauma and post-traumatic stress syndrome are common in kids with type 1 diabetes, they have little to no impact on their diabetes self-management. However surprising this finding may be to researchers, it further stresses the need for multidisciplinary teams to care for these patients. Children suffering traumatic...
Share

European Medicine Agency’s CHMP Grants Positive Opinion to Long-Acting Growth Hormone for Patients with Pediatric Growth Hormone Deficiency

In November, the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of a marketing authorization for Ascendis Pharma’s lonapegsomatropin (TransCon hGH), a long-acting once-weekly, transiently pegylated somatropin that in the body releases somatropin, indicated for growth failure in children and adolescents aged from 3 years...
Share

Evolution of Diabetes Management: The Patient-Provider Relationship, Accessing Resources, and Surmounting Obstacles

100_Years_of_Insulin_Logo During insulin’s first century, treatments and resources for people with diabetes have steadily progressed. So, too, have relationships between the patient and the provider. A recent Endocrine Society-hosted roundtable highlighted this vital connection and how it has evolved through the decades. Leonard Thompson was 14 years old in 1922, and he was dying of type...
Share

New App Helps Parents Identify Treatable Childhood Growth Disorders Earlier

A mobile phone app can place the accurate measurement of children’s height in the hands of parents and caregivers. Preliminary data presented at the Society for Endocrinology annual conference in Edinburgh suggests that the app could reliably identify treatable growth disorders much earlier, with significant improvements in child health. Childhood growth is a strong indicator...